Bernard Souberbielle

Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial

Peter C. Taylor, Didier Saurigny, Jiří Vencovský et al. · Arthritis Research & Therapy · 2019 · 89 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Expression of a Variant of CD28 on a Subpopulation of Human NK Cells: Implications for B7-Mediated Stimulation of NK Cells

Joanna Galea‐Lauri, David Darling, Shu Uin Gan et al. · The Journal of Immunology · 1999 · 86 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury

Josef Ozer, Raj Chetty, J. Gerry Kenna et al. · Regulatory Toxicology and Pharmacology · 2009 · 69 citations

Medicine, Pharmacokinetics, Pharmacology +16

Safe, Long-term Hepatic Expression of Anti-HCV shRNA in a Nonhuman Primate Model

David Suhy, Shih-Chu Kao, Tin K. Mao et al. · Molecular Therapy · 2012 · 58 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI)

Helmi M’Kada, M. Munteanu, Hugo Perazzo et al. · Regulatory Toxicology and Pharmacology · 2011 · 38 citations

Medicine, Internal Medicine, Pharmacology +16